Navigation Links
Enlisting cells' protein recycling machinery to regulate plant products

UPTON, NY--Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified a new way to regulate the production of phenols, a class of plant products with a wide range of applications for humans. These compounds serve as an important source of flavors, fragrances, and pigments; some are of interest for their possible health-promoting effects; and through their contribution to the construction of plant cell walls, (poly)phenols are the major factor influencing how easy it is to convert biomass to biofuels.

"Finding ways to effectively tailor phenol synthesis toward these different purposes could have a large impact on society," said Chang-Jun Liu, who led the team conducting this research.

As described in a paper published in The Plant Cell on December 20, 2013, Liu's team-including postdoctoral research associates Xuebin Zhang and Mingyue Gou-explored an unconventional approach to achieve this goal. The conventional approach takes aim at the regulation of genes that instruct plant cells to make enzymes involved in phenol production. These enzymes are proteins that serve as catalysts to speed up the chemical reactions that synthesize phenols. Instead of trying to regulate how these enzymes are produced, Liu's group looked at how the enzymes might be manipulated after production to control their ability to make plant phenols.

"We know that turning genes on or off can control enzyme levels, therefore influencing the yield of plant products such as phenols," said Liu. "But plants have also developed a very sophisticated system for removing and recycling aberrant or unnecessary proteins/enzymes, and they use this system to regulate their levels. Our goal was to understand how this recycling system might be used to control phenol production."

Recycling machinery

The cellular protein recycling machinery consists of various parts that work together to first identify and biochemically tag the proteins to be broken down, and then feed the unwanted molecules into a structure somewhat analogous to a garbage disposal, which breaks down the molecular components so the cell can reuse them. "We were specifically interested in identifying the components of this system that specify the particular proteins/enzymes to be broken down-which initiates the turnover process for the targeted proteins," Liu said.

The scientists' main finding was the discovery of three such components (called F-box proteins) that specifically recognize the first key enzyme in the series of phenol synthesis reactions. The scientists showed that these three F-box proteins interact with the enzyme (phenylalanine ammonia-lyase, or PAL), leading to its degradation.

They further demonstrated that turning on the genes encoding the F-box proteins reduced the cellular level of PAL in living plant cells. Reduced levels of PAL, in turn, resulted in lower levels of certain plant phenols.

One of the affected products was lignin, a polyphenol that is a component of plant cell walls. Lignin makes biomass particularly hard to break down and convert into liquid fuels. Plants with lower levels of lignin should be easier to convert.

"This strategy of increasing PAL degradation to reduce cell-wall lignin levels could therefore be used to make plant matter easier to break down, thereby improving the ease and efficiency of biofuel production," Liu said.

While the goal of this work was to learn how to improve plant biofuel feedstocks, knowing how to manipulate plant phenols may be useful for other goals, said Liu. For example, the set of molecular tools identified in this study might be used to increase the synthesis of certain phenols that have been shown to exhibit antioxidant properties, which could potentially enhance the health benefits of so-called functional foods.


Contact: Karen McNulty Walsh
DOE/Brookhaven National Laboratory

Related biology news :

1. Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation
2. Preferable treatment for MS found in allogenic bone marrow stem cells
3. Scientists find a groovy way to influence specialization of stem cells
4. Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells
5. New hope for stem cells, regenerative medicine emerges from the lab
6. Microprinting leads to low-cost artificial cells
7. Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells
8. Spontaneous fusion with macrophages empowers cancer cells to spread
9. New discovery on how skin cells form bridges paves the way for advances in wound healing
10. Precise docking sites for cells
11. Quantum effects help cells capture light, but the details are obscure
Post Your Comments:
Related Image:
Enlisting cells' protein recycling machinery to regulate plant products
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Sensors - Technology and Patent Infringement Risk Analysis" ... --> Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:11/18/2015)... new scientific discoveries deepen our understanding of how cancer ... challenges in better using that knowledge to guide treatment ... children continue to survive pediatric cancer, that counseling may ... John M. Maris, M.D ., a pediatric oncologist ... --> John M. Maris, M.D ., ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... 1, 2015 Frost & Sullivan is ... program addresses ways companies can innovate and transform ... --> ... --> ... well as the disrupting factors altering the industry, ...
(Date:12/1/2015)... , Dec. 1, 2015  CardioCell LLC, a ... stem cells for cardiovascular indications, intends to proceed ... based on recommendations from a Heart Failure Advisory ... Scientific Advisory Board members . In a ... Phase IIa safety and efficacy data from CardioCell,s ...
(Date:12/1/2015)...  Symic, a clinical-stage biotherapeutics company developing multiple compounds ... announced that it has secured $25 million in a ... its lead candidates SB-030 and SB-061. The financing was ... all existing major investors, as well as several new ... by Symic to over $43 million since being founded ...
(Date:12/1/2015)... ... December 01, 2015 , ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined Texas ... oversee all IVF lab procedures as well as continue his research efforts into the ... miles to Auckland, New Zealand to bring home a High Complexity Clinical Laboratory Director ...
Breaking Biology Technology: